Document is current
Any future updates will be listed below
-
Authors
Vierboom, Michel P. M. http://orcid.org/0000-0002-1865-7532
Chenine, Agnes L.
Darrah, Patricia A. http://orcid.org/0000-0002-0035-2802
Vervenne, Richard A. W.
Boot, Charelle
Hofman, Sam O. http://orcid.org/0000-0002-0174-1375
Sombroek, Claudia C.
Dijkman, Karin http://orcid.org/0000-0002-5395-505X
Khayum, Mohamed A.
Stammes, Marieke A.
Haanstra, Krista G. http://orcid.org/0000-0002-7654-5096
Hoffmann, Chantal
Schmitt, Doris
Silvestre, Nathalie
White, Alexander G.
Borish, H. Jacob
Seder, Robert A. http://orcid.org/0000-0003-3133-0849
Ouaked, Nadia http://orcid.org/0000-0003-4963-3688
Leung-Theung-Long, Stephane
Inchauspé, Geneviève
Anantha, Ravi
Limbach, Mary http://orcid.org/0000-0002-4726-6020
Evans, Thomas G.
Casimiro, Danilo
Lempicki, Maria
Laddy, Dominick J.
Bonavia, Aurelio
Verreck, Frank A. W.
- License Information
-
More Information
Article History
Received: 18 December 2019
Accepted: 8 April 2020
First Online: 14 May 2020
Competing interests
: The authors from the BPRC, University of Pittsburgh, and NIH have no competing interests. IAVI (transferred from Aeras 2018) holds the patent to the classical 5Ag cassette. A.B., R.A., D.J.L., and T.G.E. are listed as an inventor on a patent application originally filed by Aeras. GlaxoSmithKline Biologicals SA and Transgene are the respective developers of the investigational vaccines in this study. N.O. is an employee and shareholder of the GSK group of companies and is listed as an inventor on a patent application filed by the GSK group of companies. Remaining authors of Aeras and Transgene have no competing interests.
